Binding Mode and Structure–Activity Relationships around Direct Inhibitors of the Nrf2–Keap1 Complex
Eric Jnoff, Claudia Albrecht, John J. Barker et al. · ChemMedChem · 2014
An X-ray crystal structure of Kelch-like ECH-associated protein (Keap1) co-crystallised with (1S,2R)-2-[(1S)-1-[(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)methyl]-1,2,3,4-tetrahydroisoquinolin-2-carbonyl]cyclohexane-1-carboxylic acid (compound (S,R,S)-1 a) was obtained. This X-ray crystal structure provides breakthrough experimental evidence for the true binding mode of the hit compound (S,R,S)-1 a, as the ligand orientation was found to differ from that of the initial docking model, which was available at the start of the project. Crystallographic elucidation of this binding mode helped to focus and drive the drug design process more effectively and efficiently.
Cited by 176 works. doi:10.1002/cmdc.201300525
Authors
- Eric Jnoff
- Claudia Albrecht
- John J. Barker
- Oliver Barker
- Edward Beaumont
- Steven M. Bromidge
- Frederick A. Brookfield
- Mark Brooks
- Christian Bubert
- Tom Ceska
- Vincent Corden
- Stéphanie Duclos
- Tara Fryatt
- Christophe Génicot
- Émilie Jigorel
- Rosemary Maghames
- Innocent Mushi
References
- Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain
- Nrf2, a Cap'n'Collar Transcription Factor, Regulates Induction of the Heme Oxygenase-1 Gene
- Regulatory Mechanisms Controlling Gene Expression Mediated by the Antioxidant Response Element
- Nrf2:INrf2 (Keap1) signaling in oxidative stress
- An Important Role of Nrf2-ARE Pathway in the Cellular Defense Mechanism
- Oxidative stress in health and disease: The therapeutic potential of Nrf2 activation
- Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling
- Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte
- Small Molecule Modulators of K eap1‐ N rf2‐ ARE Pathway as Potential Preventive and Therapeutic Agents
- Expression of Nrf2 in Neurodegenerative Diseases